Intuitive Surgical Inc
ISRG: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$916.00 | Jqfbw | Zxjcmymg |
Intuitive's Strong Q3 Revenue Growth Speaks of Recovery Despite Delta Variant
We are maintaining our fair value estimate of $175 for wide-moat Intuitive Surgical following third-quarter results and preliminary data from the Ion endoluminal system’s multicenter clinical trial, Precise. We currently view shares as overvalued.